Conclusion
Analysis of residual solvents in pharmaceuticals
Article REF: P3260 V2
Conclusion
Analysis of residual solvents in pharmaceuticals

Authors : Michel BAUER, Gwenola BURGOT

Publication date: March 10, 2020 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

4. Conclusion

Solvents, including water, are an integral part of the drug production process. Given their potentially negative impact on pharmaceutical properties (toxicity, manufacturability, stability), their residual content must be kept as low as possible. Finding them is an essential part of any registration dossier for marketing authorization. This article should enable readers to implement an effective methodology that is accepted in all countries.

Thanks

We would like to thank Franck Bourbon, Anne Chambaudy, Geneviève Delerm-Germès, Jean-Pierre Guimbard, Juliette de Miras, Florence Persée, Guy Taulelle and Marlène Vallerugo for their invaluable help in preparing this article.

...
You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Drugs and pharmaceuticals"

( 124 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us